Joseph S. Zakrzewski, Director at SANGAMO THERAPEUTICS, INC (SGMO), bought 5,000 shares at $4.99 ($25K) on 2020-03-17, disclosed to the SEC on 2020-03-19.
Open-market purchase of $25k SGMO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |